This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
Questions about our CME?
Questions about our CME?

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Comprehensive Approaches to OAB in the Elderly with Comorbidities

Comprehensive Approaches to OAB in the Elderly with Comorbidities

Format

Patient Case Study

Time to Complete

30 minutes

Released

May 31, 2017

Expires

May 30, 2018
Add to Queue


Maximum Credits

0.50 / AMA PRA Category 1 CreditTM
0.50 / CNE Contact Hour
1.00 / CPD Credit

Accredited Provider

This activity is provided by Global Education Group.

Commercial Supporter

This activity is supported by an educational grant from Astellas.

Producer

Produced by Haymarket Medical Education (HME)

Program Description

Comorbidities and polypharmacy are often common in older individuals who present with overactive bladder (OAB); patients may need to be screened for other possible causes of urinary urgency. First-line therapy for OAB is always lifestyle interventions. Second–line treatments include antimuscarinics or a beta-3 adrenergic agent. Moreover, a combination of changes in lifestyle with drug therapy may be more effective than either treatment on its own in older individuals. This case report describes in detail treatment selection, and the adjustments that often must be considered and implemented, in an older patient with OAB who presents with multiple comorbidities.

Intended Audience

Urologists, urogynecologists, obstetrician-gynecologists (ob-gyns), primary care clinicians, nurse practitioners (NPs), physician assistants (PAs), nurses, and other healthcare providers who treat patients with bladder dysfunction

Educational Objectives

After completing this activity, the participant should be better able to:

  • Evaluate OAB, particularly in the presence of comorbidities, considering the impact on quality of life
  • Inform patients about current and emerging therapeutic options and strategies for managing OAB, focusing on the patient’s needs and assessing efficacy, tolerability, and optimal adherence
  • Engage in more effective patient dialogues to identify the patient’s needs and improve outcomes for OAB
  • Provide proper counseling and support to patients with OAB to increase their motivation for treatment-plan adherence and to improve patient quality of life

Conflict Of Interest Disclosure Policy

Global Education Group (Global) requires instructors, planners, managers, and other individuals and their spouse/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Faculty

Martin Wehling, MD
Professor of Clinical Pharmacology
University of Heidelberg
Mannheim, Germany

Martin Wehling, MD, is a consultant for and on the speakers bureau for Pfizer.

Publishing/Accreditor Staff Disclosures

Andrea Funk, Ashley Marostica, RN, MSN, and Karen Kaufman of Global Education Group have nothing to disclose in regard to commercial interests.

Susan Basilico, Angie Ladas, and Nick Zittell of Haymarket Medical Education have nothing to disclose in regard to commercial interests.

Credit

0.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Global Education Group designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

0.50

Type

CNE Contact Hour(s)

Accreditation Statement

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

This educational activity for 0.50 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

Learning Credit(s)

Accreditation Statement

Suggested CPD credit for UK clinicians.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

There is no fee for this activity.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Astellas, Global Education Group, or Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 0.50 AMA PRA Category 1 CreditTM and nurses are entitled to receive 0.50 CNE contact hour. UK clinicians are entitled to earn up to 1.00 CPD credit. A statement of credit will be available to print from your CME History on myCME. Users must:

  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Successfully complete the post-test, activity evaluation, and claim credit. A post-test score of 70% or higher is required, and you may retake the post-test up to 2 times to achieve a passing score.
  • Your certificate will be available to print from your CME History, located under My Account.

If you have any questions relating to the accreditation of this activity, please contact Global Education Group at 303-395-1782 or inquire@globaleducationgroup.com.

If you have any questions relating to other issues with this activity, please contact myCME.Support@haymarketmedical.com.
Add to Queue